Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
365,1 USD | -0,16% | +1,22% | +3,12% |
05:11 | Verlies Everest Medicines neemt toe in 2023 | MT |
24/04 | India inspecteert faciliteiten van specerijenfabrikanten MDH en Everest, toezichthouder zegt | RE |
Omzet 2024 * | 17,24 mld. 16,08 mld. | Omzet 2025 * | 18,66 mld. 17,41 mld. | Marktkapitalisatie | 17,83 mld. 16,64 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 2,66 mld. 2,49 mld. | Nettowinst (verlies) 2025 * | 3,01 mld. 2,81 mld. | EV/omzet 2024 * | 1,03 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,96 x |
K/w-verhouding 2024 * |
6
x | K/w-verhouding 2025 * |
5,31
x | Werknemers | 2.844 |
Dividendrendement 2024 * |
1,96% | Dividendrendement 2025 * |
2,07% | Vrij verhandelbaar | 62,6% |
Recentste transcriptie over Everest Group, Ltd.
1 dag | -0,10% | ||
1 week | +1,22% | ||
Lopende maand | -8,27% | ||
1 maand | -6,96% | ||
3 maanden | -3,17% | ||
6 maanden | -8,08% | ||
Lopend jaar | +3,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Juan Andrade
CEO | Chief Executive Officer | 58 | 01-09-19 |
Mike Karmilowicz
CHM | Chairman | 55 | - |
Mark Kociancic
DFI | Director of Finance/CFO | 54 | 12-10-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Meryl Hartzband
BRD | Director/Board Member | 69 | 23-05-19 |
John Amore
BRD | Director/Board Member | 75 | 19-09-12 |
Juan Andrade
CEO | Chief Executive Officer | 58 | 01-09-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
14.79% | 215 M€ | +12,57% | - | |
2.07% | 16 M€ | -3,37% | ||
0.51% | 393 M€ | +4,55% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 364,6 | -0,31% | 26 189 |
24-04-24 | 365,7 | -0,79% | 335 991 |
23-04-24 | 368,7 | -1,12% | 285 044 |
22-04-24 | 372,8 | +0,70% | 233 613 |
19-04-24 | 370,3 | +2,79% | 425 229 |
uitgestelde koers Nyse, 25 april 2024 om 17:44 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,12% | 17,83 mld. | |
+12,82% | 61,55 mld. | |
+5,27% | 29,91 mld. | |
+11,61% | 11,59 mld. | |
+4,22% | 2,07 mld. | |
-7,02% | 1,57 mld. | |
+6,40% | 985 mln. | |
-7,52% | 647 mln. | |
+39,78% | 634 mln. | |
+7,27% | 435 mln. |